Indications
Therapeutic Asset Ratings
9,920 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Oncolytic Adenovirus Ad5-Dnx-2401
Malignant Glioma
M.D. Anderson Cancer Center
P1
CC
(43)
Oncolytic Measles Virus Encoding Helicobacter Pylori Neutrophil-Activating Protein
Invasive Breast Carcinoma
Mayo Clinic
P1
CC
(43)
Oncolytic Measles Virus Encoding Helicobacter Pylori Neutrophil-Activating Protein
Breast Adenocarcinoma
Mayo Clinic
P1
CC
(43)
Oncolytic Measles Virus Encoding Helicobacter Pylori Neutrophil-Activating Protein
Breast Carcinoma
Mayo Clinic
P1
CC
(43)
Onm-501
In Situ Carcinoma
OncoNano Medicine, Inc.
P1
CC
(43)
Onm-501
Cervical Cancer
OncoNano Medicine, Inc.
P1
CC
(43)
Ono-7913
Colorectal Cancer
Ono Pharmaceutical Co., Ltd.
P1
CC
(43)
op-3136
Metastatic Prostate Carcinoma
Olema Pharmaceuticals, Inc.
P1
CC
(43)
op-3136
Non-Small Cell Lung Carcinoma
Olema Pharmaceuticals, Inc.
P1
CC
(43)
Opakalim
Erythromelalgia
Biohaven Therapeutics Ltd.
P1
CC
(43)
Opb-101
Ovarian Cancer
Outpace Bio, Inc.
P1
CC
(43)
Opb-201
Endometrial Carcinoma
Outpace Bio, Inc.
P1
CC
(43)
Opemalirsen
Kidney Failure
AstraZeneca
P1
CC
(43)
Opn-6602
Plasma Cell Myeloma
Opna Bio LLC
P1
CC
(43)
Optimized Neoantigen Synthetic Long Peptide Vaccine
Infiltrating Bladder Urothelial Carcinoma
Washington University School of Medicine
P1
CC
(43)
Orca-Q
Secondary Progressive Multiple Sclerosis
Stanford University
P1
CC
(43)
Orca-Q
Primary Progressive Multiple Sclerosis
Stanford University
P1
CC
(43)
Orca-T
CD4+/CD56+ Hematodermic Neoplasm
Orca Biosystems, Inc.
P1
CC
(43)
Oric-114
Non-Small Cell Lung Carcinoma
ORIC Pharmaceuticals
P1
CC
(43)
Oricar-017
Cardiovascular Disorder
OriCell Therapeutics Co., Ltd.
P1
CC
(43)
Oricar-017
Hematologic Disorder
OriCell Therapeutics Co., Ltd.
P1
CC
(43)
Oricar-017
Hemorrhagic Disease
OriCell Therapeutics Co., Ltd.
P1
CC
(43)
Oricar-017
Vascular Hemostatic Disease
OriCell Therapeutics Co., Ltd.
P1
CC
(43)
Oricar-017
Immune System Disorder
OriCell Therapeutics Co., Ltd.
P1
CC
(43)
Oricar-017
Immunoproliferative Disorder
OriCell Therapeutics Co., Ltd.
P1
CC
(43)
Showing 3651 to 3675 of 9,920 assets
Previous
Page 147 of 397
Next
